These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas]. Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047 [TBL] [Abstract][Full Text] [Related]
14. Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience. Srinivasan A; McLaughlin L; Wang C; Srivastava DK; Shook DR; Leung W; Hayden RT Transpl Infect Dis; 2014 Feb; 16(1):90-7. PubMed ID: 24256514 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center. Linke C; Tragiannidis A; Ahlmann M; Fröhlich B; Wältermann M; Burkhardt B; Rossig C; Groll AH Mycoses; 2019 Oct; 62(10):954-960. PubMed ID: 31332851 [TBL] [Abstract][Full Text] [Related]
16. Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry. Hazar V; Kesik V; Karasu GT; Öztürk G; Küpesiz A; Kılıç SÇ; Ataş E; Uygun V; Eker N; Erbey F; Bengoa ŞY; Emir S; Anak S; Öniz H; Daloğlu H; Aksoylar S; Koçak Ü; Karakükçü M; Elli M; Kurucu N; Yeşilipek A Leuk Lymphoma; 2018 Jan; 59(1):85-96. PubMed ID: 28571522 [TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant bacterial infections in children undergoing haematopoietic stem cell transplantation over a 6-year period: analysis of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation. Zając-Spychała O; Wachowiak J; Frączkiewicz J; Salamonowicz M; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Dziedzic M; Wysocki M; Zalas-Wiącek P; Zaucha-Prażmo A; Kowalczyk JR; Goździk J; Styczyński J J Appl Microbiol; 2020 Jan; 128(1):292-300. PubMed ID: 31529556 [TBL] [Abstract][Full Text] [Related]
18. Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Osumi T; Mori T; Fujita N; Saito AM; Nakazawa A; Tsurusawa M; Kobayashi R Pediatr Blood Cancer; 2016 Oct; 63(10):1794-9. PubMed ID: 27314926 [TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas. Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology and outcome of invasive fungal disease in children after hematopoietic cell transplantation or treated for malignancy: Impact of national programme of antifungal prophylaxis. Czyżewski K; Gałązka P; Frączkiewicz J; Salamonowicz M; Szmydki-Baran A; Zając-Spychała O; Gryniewicz-Kwiatkowska O; Zalas-Więcek P; Chełmecka-Wiktorczyk L; Irga-Jaworska N; Bień E; Ociepa T; Wawryków P; Tomaszewska R; Płonowski M; Pierlejewski F; Gamrot-Pyka Z; Małas Z; Urbanek-Dądela A; Stolpa W; Zaucha-Prażmo A; Goździk J; Chaber R; Gil L; Styczyński J Mycoses; 2019 Nov; 62(11):990-998. PubMed ID: 31429997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]